Tools for Optimizing Medication Safety (TOP-MEDS)
优化用药安全的工具 (TOP-MEDS)
基本信息
- 批准号:8265048
- 负责人:
- 金额:$ 84.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): We propose a patient safety CERT focused on the theme of Tools for Optimizing Medication Safety (TOPMEDS). The long term goal is to improve patient safety by developing and refining tools for safer medication use. The short term objective is to develop, test, deploy and disseminate tools and training materials in four key areas: statistical methods for large-scale studies of comparative drug safety and effectiveness, opioid prescribing and dosing for acute pain, methods for preventing and detecting drug name confusion errors, and patient-centered, language concordant drug information. We will carry out studies with the following specific aims: 1. Develop and apply a multivariate, person-time logistic
regression model for large-scale adverse drug event screening. 2. Improve the safety and effectiveness of inpatient acute pain care by developing and validating a novel, web-based simulator to train prescribers in the proper selection and dosing of opioids. 3. Refine a standard battery of tests for pre-market safety screening of drug names, and develop and test methods for preventing and detecting drug name confusion errors using electronic medical records. 4. Rigorously evaluate a low literacy strategy for promoting safe and effective prescription medication use among English and Spanish-speaking patients in an urban primary care setting. Together the projects address all five of the programmatic interest areas: comparative effectiveness, patient safety, development of tools, health care system interventions, and translation into policy or practice. UIC will host the center, with collaborators at Rush Universit Medical Center, Northwestern University, University of Chicago, the Brigham and Women's Hospital, Discerning Systems, Inc., the Institute for Safe Medication Practices, and the National Patient Safety Foundation. Our investigators are national and international leaders in statistics (Robert Gibbons), health literacy (Michael Wolf), drug name confusion (Bruce Lambert), health information technology (Gordon Schiff, Bill Galanter), pain care (Robert McNutt and Diana Wilkie) medication error prevention (Michael Cohen) and patient safety (Tim McDonald, Diane Pinakiewicz).
PUBLIC HEALTH RELEVANCE: Patients are not as safe as they should be. Medication errors and inappropriate use of medicines, by health professionals and patients, cause a great deal of harm. The proposed research will make patients safer by developing and sharing tools for safer medication use, including tools for detecting drug risks, for training young doctors, for preventin medication errors and for making drug information easier to understand.
描述(由申请人提供):我们提出了一项患者安全性CERT,重点关注优化药物安全性工具(TOPMEDS)的主题。长期目标是通过开发和改进更安全的药物使用工具来提高患者安全性。短期目标是在四个关键领域开发、测试、部署和传播工具和培训材料:比较药物安全性和有效性的大规模研究的统计方法,急性疼痛的阿片类药物处方和剂量,预防和检测药物名称混淆错误的方法,以及以患者为中心的语言一致的药物信息。我们会进行以下的研究:1.开发和应用一个多元的,人的时间物流
大规模药物不良事件筛查的回归模型。2.通过开发和验证一种新型的基于网络的模拟器来培训处方者正确选择和给药阿片类药物,从而提高住院急性疼痛护理的安全性和有效性。3.完善药品名称上市前安全性筛选的标准测试组合,并开发和测试使用电子病历预防和检测药品名称混淆错误的方法。4.严格评估一项低识字率战略,以促进城市初级保健环境中讲英语和西班牙语的患者安全有效地使用处方药。这些项目共同解决了所有五个方案感兴趣的领域:比较有效性,患者安全,工具开发,医疗保健系统干预以及转化为政策或实践。UIC将主办该中心,与拉什大学医学中心,西北大学,芝加哥大学,布里格姆妇女医院,识别系统公司,安全用药实践研究所和国家患者安全基金会。我们的研究人员是统计学(罗伯特·吉本斯)、健康素养(迈克尔·沃尔夫)、药品名称混淆(布鲁斯·兰伯特)、健康信息技术(戈登·希夫、比尔·加兰特)、疼痛护理(罗伯特·麦克纳特和戴安娜·威尔基)、用药错误预防(迈克尔·科恩)和患者安全(蒂姆·麦克唐纳、黛安·皮纳凯维奇)方面的国家和国际领导者。
公共卫生相关性:患者不像他们应该的那样安全。保健专业人员和病人的用药错误和用药不当造成很大伤害。拟议的研究将通过开发和共享更安全的药物使用工具来使患者更安全,包括检测药物风险的工具,培训年轻医生,预防用药错误和使药物信息更容易理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE L. LAMBERT其他文献
BRUCE L. LAMBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE L. LAMBERT', 18)}}的其他基金
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
通过 CPOE 系统中的指示警报防止错误药物和错误患者错误
- 批准号:
9356494 - 财政年份:2016
- 资助金额:
$ 84.88万 - 项目类别:
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
通过 CPOE 系统中的指示警报防止错误药物和错误患者错误
- 批准号:
10013218 - 财政年份:2016
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Medication Safety (TOP-MEDS)
优化用药安全的工具 (TOP-MEDS)
- 批准号:
8739629 - 财政年份:2011
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Medication Safety (TOP-MEDS)
优化用药安全的工具 (TOP-MEDS)
- 批准号:
8492029 - 财政年份:2011
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Medication Safety (TOP-MEDS)
优化用药安全的工具 (TOP-MEDS)
- 批准号:
8335145 - 财政年份:2011
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Medication Safety (TOP-MEDS)
优化用药安全的工具 (TOP-MEDS)
- 批准号:
8917143 - 财政年份:2011
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Prescribing, Monitoring and Education
优化处方、监测和教育的工具
- 批准号:
7874547 - 财政年份:2007
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Prescribing, Monitoring and Education
优化处方、监测和教育的工具
- 批准号:
7489964 - 财政年份:2007
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Prescribing, Monitoring and Education
优化处方、监测和教育的工具
- 批准号:
7333917 - 财政年份:2007
- 资助金额:
$ 84.88万 - 项目类别:
Tools for Optimizing Prescribing, Monitoring and Education
优化处方、监测和教育的工具
- 批准号:
7686747 - 财政年份:2007
- 资助金额:
$ 84.88万 - 项目类别:
相似海外基金
Optimizing Medication and Vaccination Adherence in Rheumatoid Arthritis in the COVID-19 Era: Development of a Patient-Centered Intervention
优化 COVID-19 时代类风湿关节炎的药物和疫苗接种依从性:制定以患者为中心的干预措施
- 批准号:
475809 - 财政年份:2022
- 资助金额:
$ 84.88万 - 项目类别:
Studentship Programs
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).
改善药物依从性和血压控制的优化技术 (OPTIMA-BP)。
- 批准号:
10470340 - 财政年份:2021
- 资助金额:
$ 84.88万 - 项目类别:
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).
改善药物依从性和血压控制的优化技术 (OPTIMA-BP)。
- 批准号:
10294577 - 财政年份:2021
- 资助金额:
$ 84.88万 - 项目类别:
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).
改善药物依从性和血压控制的优化技术 (OPTIMA-BP)。
- 批准号:
10611508 - 财政年份:2021
- 资助金额:
$ 84.88万 - 项目类别:
Best practices for pharmacists in medication management for opioid use disorder - expanding access and optimizing integration of care during COVID-19 pandemic and going forward
药剂师在阿片类药物使用障碍药物管理方面的最佳实践 - 在 COVID-19 大流行期间和未来扩大护理的可及性并优化护理整合
- 批准号:
432608 - 财政年份:2020
- 资助金额:
$ 84.88万 - 项目类别:
Operating Grants
Optimizing medication regimens for people living with multiple chronic conditions
优化多种慢性病患者的药物治疗方案
- 批准号:
396745 - 财政年份:2018
- 资助金额:
$ 84.88万 - 项目类别:
Fellowship Programs
Optimizing Medication-Assisted Therapy for Opioid Dependence in Ukraine: HIV Impact Modeling and Cost-Effectiveness Evaluation
优化乌克兰阿片类药物依赖的药物辅助治疗:艾滋病毒影响模型和成本效益评估
- 批准号:
9200064 - 财政年份:2016
- 资助金额:
$ 84.88万 - 项目类别:
Optimizing Medication-Assisted Therapy for Opioid Dependence in Ukraine: HIV Impact Modeling and Cost-Effectiveness Evaluation
优化乌克兰阿片类药物依赖的药物辅助治疗:艾滋病毒影响模型和成本效益评估
- 批准号:
9330145 - 财政年份:2016
- 资助金额:
$ 84.88万 - 项目类别:
Optimizing Medication Reconciliation for Older Veterans in Home Health Care
优化家庭医疗保健中老年退伍军人的药物协调
- 批准号:
8596257 - 财政年份:2013
- 资助金额:
$ 84.88万 - 项目类别:
Bending the asthma cost curve: Is optimizing medication the answer?
弯曲哮喘成本曲线:优化药物治疗是答案吗?
- 批准号:
8488611 - 财政年份:2013
- 资助金额:
$ 84.88万 - 项目类别: